Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28815299 | 0.80 | PDK2 (0.33) | LMNATSHRALOX12ACHE | |
| SCHEMBL2047468 | 0.77 | PDK2 (0.34) | LMNATSHRALOX12ACHE | |
| Ammonia Solution, Strong SCHEMBL7083566 | 0.76 | PDK2 (0.33) | LMNATSHRALOX12ACHE | |
| SCHEMBL7941719 | 0.74 | PDK2 (0.33) | LMNATSHRALOX12ACHE | |
| SCHEMBL6351669 | 0.74 | PGR (0.31) | LMNATSHRALOX12ACHE | |
| SCHEMBL1675908 | 0.74 | HTR2A (0.31) | LMNATSHRALOX12ACHE | |
| SCHEMBL22616659 | 0.74 | LMNA (0.31) | LMNATSHRALOX12ACHE | |
| SCHEMBL4652584 | 0.74 | LMNA (0.31) | LMNATSHRALOX12ACHE | |
| Hydrochloric Acid SCHEMBL6346400 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL6346406 | 0.72 | PGR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | PCBP1, SOD1, PCLAF | LMNA 3423/4885TSHR 4767/4885ALOX12 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.